Document
IPR2017-00807, No. 1149-305 Exhibit - Nairn (P.T.A.B. Mar. 6, 2018)
Cite Document
IPR2017-00807, No. 1149-305 Exhibit - Nairn (P.T.A.B. Mar. 6, 2018)
+ More Snippets
Document
IPR2017-00807, No. 1068-227 Exhibit - Meda, Annual Report 2013 (P.T.A.B. Mar. 6, 2018)
Cite Document
IPR2017-00807, No. 1068-227 Exhibit - Meda, Annual Report 2013 (P.T.A.B. Mar. 6, 2018)
+ More Snippets
Document
IPR2017-00807, No. 1067-226 Exhibit - Meda, Annual Report 2014 (P.T.A.B. Mar. 6, 2018)
Cite Document
IPR2017-00807, No. 1067-226 Exhibit - Meda, Annual Report 2014 (P.T.A.B. Mar. 6, 2018)
+ More Snippets
Document
IPR2017-00807, No. 1110-269 Exhibit - Nasalide Drug Approval (P.T.A.B. Mar. 6, 2018)
Cite Document
IPR2017-00807, No. 1110-269 Exhibit - Nasalide Drug Approval (P.T.A.B. Mar. 6, 2018)
+ More Snippets
Document
IPR2017-00807, No. 1070-229 Exhibit - Beclomethasone (P.T.A.B. Mar. 6, 2018)
Cite Document
IPR2017-00807, No. 1070-229 Exhibit - Beclomethasone (P.T.A.B. Mar. 6, 2018)
+ More Snippets
Document
IPR2017-00807, No. 1106-265 Exhibit - Apotex Launches First Generic Version of Mercks Nasonex (P.T.A.B. Mar. 6, 2018)
Cite Document
IPR2017-00807, No. 1106-265 Exhibit - Apotex Launches First Generic Version of Mercks Nasonex (P.T.A.B. Mar. 6, 2018)
+ More Snippets
Document
IPR2017-00807, No. 1096-255 Exhibit - Yi (P.T.A.B. Mar. 6, 2018)
Cite Document
IPR2017-00807, No. 1096-255 Exhibit - Yi (P.T.A.B. Mar. 6, 2018)
+ More Snippets
Document
IPR2017-00807, No. 1114-273 Exhibit - Olopatadine (P.T.A.B. Mar. 6, 2018)
Cite Document
IPR2017-00807, No. 1114-273 Exhibit - Olopatadine (P.T.A.B. Mar. 6, 2018)
+ More Snippets
Document
IPR2017-00807, No. 1120-279 Exhibit - Bhargava (P.T.A.B. Mar. 6, 2018)
Cite Document
IPR2017-00807, No. 1120-279 Exhibit - Bhargava (P.T.A.B. Mar. 6, 2018)
+ More Snippets
Document
IPR2017-00807, No. 1119-278 Exhibit - Kataria (P.T.A.B. Mar. 6, 2018)
Cite Document
IPR2017-00807, No. 1119-278 Exhibit - Kataria (P.T.A.B. Mar. 6, 2018)
+ More Snippets
Document
IPR2017-00807, No. 1073-232 Exhibit - 2010 Top 200 Branded Drugs by Retail Dollars (P.T.A.B. Mar. 6, 2018)
Cite Document
IPR2017-00807, No. 1073-232 Exhibit - 2010 Top 200 Branded Drugs by Retail Dollars (P.T.A.B. Mar. 6, 2018)
+ More Snippets
Document
Meda Pharmaceuticals Inc. et al v. Apotex Inc. et al, 1:14-cv-01453, No. 107 (D.Del. Apr. 18, 2016)
Cite Document
Meda Pharmaceuticals Inc. et al v. Apotex Inc. et al, 1:14-cv-01453, No. 107 (D.Del. Apr. 18, 2016)
+ More Snippets
Document
Meda Pharmaceuticals Inc. et al v. Apotex Inc. et al, 1:14-cv-01453, No. 33 (D.Del. Aug. 12, 2015)
Cite Document
Meda Pharmaceuticals Inc. et al v. Apotex Inc. et al, 1:14-cv-01453, No. 33 (D.Del. Aug. 12, 2015)
+ More Snippets
Document
Meda Pharmaceuticals Inc. et al v. Apotex Inc. et al, 1:14-cv-01453, No. 20 (D.Del. Apr. 22, 2015)
Cite Document
Meda Pharmaceuticals Inc. et al v. Apotex Inc. et al, 1:14-cv-01453, No. 20 (D.Del. Apr. 22, 2015)
+ More Snippets
Document
Meda Pharmaceuticals Inc. et al v. Apotex Inc. et al, 1:14-cv-01453, No. 25 (D.Del. May. 13, 2015)
Cite Document
Meda Pharmaceuticals Inc. et al v. Apotex Inc. et al, 1:14-cv-01453, No. 25 (D.Del. May. 13, 2015)
+ More Snippets